We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a ...

“We were probably one of the lucky few that was able to go out last fall and have such a strong and successful IPO,” Bicara ...

We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going ...

Summit Therapeutics is making strides with ivonescimab, but upcoming trial results and financial challenges suggest caution.

Merck is holding strong among billionaire favorites, despite the broader healthcare sector dodging investor affection like a ...

The global surgical sutures market size has witnessed significant advancements in recent years, driven by an increasing number of surgical procedures and improvements in medical technologies. Surgical ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Summit Therapeutics (NASDAQ: SMMT), and Viking Therapeutics (NASDAQ: VKTX) as stocks worth buying now. (CRISPR Therapeutics): Despite creating Casgevy, the first CRISPR-based gene-editing medicine to ...

Merck is juggling shareholder rebellion and market turbulence ahead of its annual meeting, with the company giving a firm thumbs-down to several investor proposals. This shareholder pushback adds a ...

While these stocks led growth in early 2020, their momentum eventually faded. This led to corrections instead of broadening. Investors began exploring second and third derivative trades stemming from ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

A major step forward has been made in predicting how well melanoma patients would respond to treatment, thanks to ...